Clinical Research Directory
Browse clinical research sites, groups, and studies.
Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers
Sponsor: City of Hope Medical Center
Summary
Gastric cancer (GC) is a leading cause of cancer-related death worldwide. Even in patients undergoing curative surgery for non-metastatic disease, postoperative recurrence frequently occurs due to undetected minimal residual disease (MRD). This study aims to establish a highly sensitive and specific liquid biopsy assay using exosomal microRNAs (exo-miRNAs) to detect MRD and predict distant metastasis before clinical recurrence.
Official title: Exosomal microRNA-based Analysis for Early detectIon of Gastric Cancer Hidden-recurrence Traces
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-01-15
Completion Date
2026-06-18
Last Updated
2025-11-21
Healthy Volunteers
No
Conditions
Interventions
small RNA-seq or array
small RNA-seq or array
ENLIGHT Assay
RT-qPCR-based exo-miRNA quantification
Locations (1)
City of Hope Medical Center
Duarte, California, United States